Canopy Growth Corp (TSE:WEED)‘s stock had its “buy” rating reissued by Canaccord Genuity in a report issued on Tuesday. They currently have a C$9.50 price objective on the stock. Canaccord Genuity’s price objective suggests a potential upside of 6.62% from the company’s current price.

Separately, Cowen and Company lowered their target price on shares of Canopy Growth Corp from C$15.00 to C$10.00 in a research note on Wednesday, June 14th.

Canopy Growth Corp (TSE WEED) traded down 1.01% on Tuesday, reaching $8.82. The company had a trading volume of 351,028 shares. The stock’s market capitalization is $1.46 billion. Canopy Growth Corp has a 52-week low of $3.65 and a 52-week high of $17.86. The stock has a 50 day moving average price of $8.48 and a 200 day moving average price of $9.43.

WARNING: “Canopy Growth Corp’s (WEED) Buy Rating Reiterated at Canaccord Genuity” was posted by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.americanbankingnews.com/2017/08/15/canopy-growth-corp-weed-pt-set-at-c9-50-by-canaccord-genuity.html.

About Canopy Growth Corp

Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company offers dried, oil, and softgel cannabis products. Canopy Growth Corporation also sells its products through online. The company was formerly known as Tweed Marijuana Inc and changed its name to Canopy Growth Corporation in September 2015.

Receive News & Ratings for Canopy Growth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth Corp and related companies with MarketBeat.com's FREE daily email newsletter.